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(Received for publication February 3, 1988) A53868A is a novel phosphorus-containing antibiotic obtained by fermentation of Streptomyces luridus NRRL15.101 ; the product has a broad-spectrum antimicrobial activity1^The molecular formula of CnH22N3O5P(MW307) contains units of glycine, leucine, and C3H7NOSP ; mass spectral fragmentation observations and 1H
NMRstudies were combined to suggest the structure 11}.
However, attempts to synthesize a series of analogs of GLAPP (1) prompted a re-examination of the structure elucidation of the parent compound, A53868A. The pattern of carbonphosphorus coupling constants in the 13C NMR spectrum (see Glycyl-leucyl-2-amino-2-propenyl-phosphonate (GLAPP, 1) 
